Eber B, Klein W
Kardiologischen Abteilung, Medizinischen Universitätsklinik Graz.
Acta Med Austriaca. 1989;16(2):27-31.
The percutaneous transluminal balloon valvuloplasty has been in use for several years as part of interventional cardiology for treating acquired aortic and mitral stenosis. In spite of a high primary success rate the difficulty of this procedure lies not only in the problem of reststenosis but also in a possible development of restenosis. In aortic stenosis the indication for valvuloplasty must be restricted to special patients, such as elderly people or those with poor left ventricular function, whereas in selected patients, mitral valvuloplasty appears as a true alternative to operative commissurotomy. There can be no doubt that by intensive patient selection and progress in the technology of balloon catheters and insertion sheaths, possibly enhanced by laser application, even better results are to be achieved in the near future.
经皮腔内球囊瓣膜成形术作为介入心脏病学的一部分，用于治疗获得性主动脉瓣和二尖瓣狭窄已有数年。尽管初次成功率很高，但该手术的困难不仅在于再狭窄问题，还在于可能发生再狭窄。在主动脉瓣狭窄中，瓣膜成形术的适应症必须限于特殊患者，如老年人或左心室功能较差的患者，而在选定的患者中，二尖瓣成形术似乎是手术交界切开术的真正替代方法。毫无疑问，通过严格的患者选择以及球囊导管和插入鞘技术的进步，可能通过激光应用得到进一步提升，在不久的将来有望取得更好的效果。
